Pulmonary Mucormycosis in a Heart Transplant Patient

Opportunistic mycosis referred to as Mucormycosis can cause fatal infections in immunocompromised and diabetic patients.1 The most common species include Rhizopus, Lichtheimia, Rhizomucor, Mucor, and Cunninghamella. Mucormycosis is an increasingly well-reported invasive fungal infection that affects solid-organ transplant (SOT) and hematopoietic stem cell transplant recipients and is associated with a high morbidity and mortality. In SOT recipients, Mucormycosis involves the lungs in 56%, sinuses or skin in 13%, and disseminated in 9% of cases.